TAVR: A Review of Current Practices and Considerations in Low-Risk Patients
Transcatheter aortic valve replacement (TAVR) is an established treatment for severe, symptomatic, aortic stenosis (AS) in patients of all risk categories and now comprises 12.5% of all aortic valve replacements. TAVR is a less invasive alternative to traditional surgical aortic valve replacement (S...
Saved in:
| Main Authors: | Jenna Spears, Yousif Al-Saiegh, David Goldberg, Sina Manthey, Sheldon Goldberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Interventional Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2020/2582938 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Apixaban as a Rare Cause of Leukocytoclastic Vasculitis
by: Jenna Spears, et al.
Published: (2020-01-01) -
A Conservative Approach to a Large Mycotic Pulmonary Pseudoaneurysm
by: Erin Torpey, et al.
Published: (2021-01-01) -
Valve-in-valve transcatheter aortic valve replacement (TAVR) leads to lower device success compared to TAVR in native stenosis
by: Michael Paukovitsch, et al.
Published: (2025-04-01) -
What’s New with TAVR? An Update on Device Technology
by: Syed Zaid, et al.
Published: (2023-05-01) -
Risk Measurement of TAVR Surgical Complications Based on Unbalanced Multilabel Classification Approaches
by: Yue Zhang, et al.
Published: (2025-06-01)